Description

n-[(Z)-[(4-Fluorophenyl)Amino]{[6-(Methoxymethyl)-4-Oxo-1,4-Dihydropyrimidin-2-Yl]Amino}Methylidene]Benzamide is a high-purity, advanced pharmaceutical intermediate with the CAS registry number 669724-30-5. This compound is valued for its role as a key building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring precise molecular architecture. It is primarily sought by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in developing novel drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of target drug molecules, especially in oncology and antiviral research.
• Organic Synthesis Building Block: Used in research-scale and process chemistry for constructing complex heterocyclic frameworks containing pyrimidine and benzamide motifs.
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and lead optimization programs to develop new therapeutic agents.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for the production of clinical trial materials and commercial APIs under GMP conditions.
• Biochemical Research: Potential use as a tool compound or inhibitor in biochemical assays to study specific enzymatic pathways.

Basic Information

Product Name	n-[(Z)-[(4-Fluorophenyl)Amino]{[6-(Methoxymethyl)-4-Oxo-1,4-Dihydropyrimidin-2-Yl]Amino}Methylidene]Benzamide
CAS No.	669724-30-5
Molecular Formula	C20H18FN5O3
Molecular Weight	395.39 g/mol
Synonyms	Benzamide, N-[(Z)-[(4-fluorophenyl)amino][[6-(methoxymethyl)-4-oxo-1,4-dihydro-2-pyrimidinyl]amino]methylene]-; 669724-30-5; (Z)-N-((4-Fluorophenyl)carbamoyl)-2-((6-(methoxymethyl)-4-oxo-1,4-dihydropyrimidin-2-yl)amino)acetimidic acid; N-[(Z)-[(4-Fluorophenyl)amino]{[6-(methoxymethyl)-4-oxo-1,4-dihydropyrimidin-2-yl]amino}methylene]benzamide; A potential intermediate for kinase inhibitors.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols. Every batch is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We ensure consistent high purity (typically >97% by HPLC) and compliance with relevant internal specifications for pharmaceutical R&D use. Certificates of Analysis (COA) are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.